Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes
Rosak, C., Petzoldt, R., Wolf, R., Reblin, T., Dehmel, B., Seidel, D.
Published in International journal of clinical practice (Esher) (01.10.2005)
Published in International journal of clinical practice (Esher) (01.10.2005)
Get full text
Journal Article
Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes
ROSAK, C., STANDL, E., REBLIN, T., STAMMER, H., SEIDEL, D. K.
Published in International journal of clinical practice (Esher) (01.09.2006)
Published in International journal of clinical practice (Esher) (01.09.2006)
Get full text
Journal Article
Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
Rosak, Christoph, Mertes, Gabriele
Published in Diabetes, metabolic syndrome and obesity (01.01.2012)
Published in Diabetes, metabolic syndrome and obesity (01.01.2012)
Get full text
Journal Article
Genetic Analysis of Adult-Onset Autoimmune Diabetes
HOWSON, Joanna M. M, ROSINGER, Silke, SMYTH, Deborah J, BOEHM, Bernhard O, TODD, John A
Published in Diabetes (New York, N.Y.) (01.10.2011)
Published in Diabetes (New York, N.Y.) (01.10.2011)
Get full text
Journal Article
Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study
Breddin, H K, Krzywanek, H J, Althoff, P, Kirchmaier, C M, Rosak, C, Schepping, M, Weichert, W, Ziemen, M, Schöffling, K, Uberla, K
Published in International angiology (01.07.1986)
Get full text
Published in International angiology (01.07.1986)
Journal Article
ORIGINAL PAPER: Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes
ROSAK, C, STANDL, E, Reblin, T, Stammer, H, Seidel, D K
Published in International journal of clinical practice (Esher) (01.09.2006)
Published in International journal of clinical practice (Esher) (01.09.2006)
Get full text
Journal Article
Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes: ROSIGLITAZONE IS EFFECTIVE IN DAILY PRACTICE
ROSAK, C., STANDL, E., REBLIN, T., STAMMER, H., SEIDEL, D. K.
Published in International journal of clinical practice (Esher) (01.09.2006)
Published in International journal of clinical practice (Esher) (01.09.2006)
Get full text
Journal Article
TcR-alpha and TcR-beta dialellic RFLPs in insulin-dependent (type I) Caucasian diabetic patients
Boehm, B O, Manfras, B J, Rosak, C, Kuehnl, P, Schöffling, K, Trucco, M
Published in Diabetes research (Edinburgh, Scotland) (01.10.1990)
Get more information
Published in Diabetes research (Edinburgh, Scotland) (01.10.1990)
Journal Article